Progress in the Treatment of Advanced-Stage Classical Hodgkin Lymphoma in the PET-Adapted Era

Introduction

Classical Hodgkin lymphoma (cHL) is a germinal center B-cell cancer, as demonstrated by somatic hypermutation and clonal immunoglobulin gene alterations.^1,2 Clinical indications of a more advanced stage of the disease include…